Dr. Jamie Scott Falkowitz, DO

Dr. Falkowitz practices at Grand Strand Medical Center in Myrtle Beach, South Carolina, part of HCA Healthcare.

Dr. Falkowitz's NPI, 1538384789, was assigned on April 14, 2007. Dr. Falkowitz holds North Carolina license 2008-00096.

Dr. Falkowitz's primary practice is Grand Strand Medical Center, at 809 82nd Parkway, Myrtle Beach, SC 29572 in Horry County. The practice phone is (843) 692-1000.

Dr. Falkowitz's primary practice is Grand Strand Medical Center in Myrtle Beach, South Carolina, part of HCA Healthcare. Dr. Falkowitz is also affiliated with MUSC Health Lancaster Medical Center. The medical group on file is MUSC Community Physicians. Dmand AI also links Dr. Falkowitz to 1 more hospital and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Falkowitz practices, 3 sites in all. Vendor and product names are available with a free account.

Emergency medicine is Dr. Falkowitz's primary specialty in the NPI Registry, under taxonomy code 207P00000X. Dmand AI has Dr. Falkowitz's licenses on file in 2 states: North Carolina and South Carolina.

CMS data shows 306 Medicare services from Dr. Falkowitz across 4 procedure codes in 2024, for 272 Medicare patients. Medicare paid $32,447 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 272 Medicare patients who saw Dr. Falkowitz in 2024. The largest group is 75 to 84, with 94 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 24% are also on Medicaid. Their average risk score is 2.02, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Falkowitz's median patient age at 43, with 60% women.

In 2024, Dr. Falkowitz wrote 198 Medicare Part D claims for 126 patients. 96% of them were for generic drugs. CMS names the drug for 116 of them, across 6 drugs with 11 or more claims each, at $713 in total drug cost. In 2023, CMS named 125 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Falkowitz for performance year 2024, reported through an alternative payment model (APM). Dr. Falkowitz accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 1 paper to Dr. Falkowitz in 2016. Dr. Falkowitz's most frequent co-authors are Dietrich Jehle, MD, John T. Molnar, MD and Radley Short, MD.

CMS Open Payments shows 1 general payment to Dr. Falkowitz from 1 drug or device company in 2024. Speaker and faculty fees make up the largest share, 100% of the total. Eko Devices, Inc. paid the most, $50.